ProfileGDS4459 / ENSG00000162062
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 58% 58% 57% 65% 64% 57% 56% 55% 58% 57% 43% 57% 57% 66% 59% 69% 64% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.7158
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.6558
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.6657
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.0265
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.9664
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.6557
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.7156
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.5855
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.7158
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.7157
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.0443
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.6857
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.7257
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9866
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.7859
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.1469
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.8964